Liang, N
Remember, the keys to success are quality and consistency
Standard glutathioneoften labeled as L-glutathioneis a fragile molecule
The markets fragmentation presents opportunities for strategic consolidation, while technological innovations promise to unlock new product categories and improve margins
2124-A VALIDATION OF A CLINICAL CARE PATHWAY TO RISK STRATIFY PATIENTS WITH NAFLD AND COMPARING FIB4 SCORING WITH OTHER NON-INVASIVE TESTING Ria Ghose Kundu 1 , Pooja Rangan 2 , Claire Faulkner 3 , Majd Aboona 3 , Dylan Grade 1 , Rahul Sharma 1 , Vir Dolasa-Sahani 1 , Naina Shaik 1 , Rayna Shaik 1 , Rida Nadeem 1 , Karn Wijarnpreecha 2 and Naim Alkhouri 1 , (1)Arizona Liver Health, Phoenix, AZ, (2)University of Arizona College of Medicine Phoenix, Phoenix, AZ, (3)University of Arizona College of Medicine, Phoenix, AZ Background: FIB4 index was originally developed to diagnose advanced fibrosis, it has been incorporated recently into algorithms by the AGA,AACE,AASLD as the initial screening test to identify patients with at-risk NASH that need referral to specialty clinics.FIB4 /=4 and fibrosis stage 2-4